Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 3
Submit an article Journal homepage
741
Views
58
CrossRef citations to date
0
Altmetric
Original

Standard CHOP-21 as first line therapy for elderly patients with Hodgkin's lymphoma

A. Kolstad Department of Medical Oncology and RadiotherapyCorrespondence[email protected]
,
O. Nome Department of Medical Oncology and Radiotherapy
,
J. Delabie Department of Pathology, Rikshospitalet-Radiumhospitalet Medical Center, Montebello, N-0310, Oslo, Norway
,
G. F. Lauritzsen Department of Medical Oncology and Radiotherapy
,
A. Fossa Department of Medical Oncology and Radiotherapy
&
H. Holte Department of Medical Oncology and Radiotherapy
Pages 570-576 | Received 20 Oct 2006, Accepted 16 Nov 2006, Published online: 01 Jul 2009

Citations (58)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ajay Major, Matthew W. Jackson, Derek E. Smith, Manali Kamdar & Rachel Rabinovitch. (2019) Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis. Leukemia & Lymphoma 60:5, pages 1234-1243.
Read now
Tomasz Wróbel, Przemysław Biecek, Justyna Rybka, Anna Szulgo, Natalia Sorbotten, Agnieszka Giza, Agata Tyczyńska, Elżbieta Nowara, Agnieszka Badora-Rybicka, Krzysztof Adamowicz, Waldemar Kulikowski, Renata Kroll-Balcerzak, Andrzej Balcerzak, Wojciech Spychałowicz, Ewa Kalinka-Warzocha, Beata Kumiega, Joanna Drozd-Sokołowska, Edyta Subocz, Agata Sałek, Maciej Machaczka, Jadwiga Hołojda, Joanna Pogrzeba, Olga Dobrzyńska, Ewa Chmielowska, Wojciech Jurczak, Wanda Knopińska-Posłuszny, Krzysztof Leśniewski-Kmak & Jan Maciej Zaucha. (2019) Hodgkin lymphoma of the elderly patients: a retrospective multicenter analysis from the Polish Lymphoma Research Group*. Leukemia & Lymphoma 60:2, pages 341-348.
Read now
Dennis A Eichenauer, Boris Böll & Volker Diehl. (2014) Pharmacotherapy of Hodgkin lymphoma: standard approaches and future perspectives. Expert Opinion on Pharmacotherapy 15:8, pages 1139-1151.
Read now
Olav E. Yri, Per O. Ekstrøm, Vera Hilden, Gustav Gaudernack, Knut Liestøl, Erlend B. Smeland & Harald Holte. (2012) Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma. Leukemia & Lymphoma 53:10, pages 1934-1944.
Read now

Articles from other publishers (54)

Andrew M. Evens, Marshall McKenna, Yun Kyoung Ryu Tiger & Jenica N. Upshaw. (2023) Hodgkin lymphoma treatment for older persons in the modern era. Hematology 2023:1, pages 483-499.
Crossref
Matthew R. Wilson, Euan Haynes, Katrina Parsons, David Hopkins, Elizabeth Robertson, Graeme Ferguson, Daire Quinn, Jim Murray, Wendy Osborne, Mike Leach & Pam McKay. (2023) ‘ ACOPP ’ chemotherapy for older and less fit patients with Hodgkin lymphoma—A multicentre, retrospective study . British Journal of Haematology 202:4, pages 796-800.
Crossref
Zhong Goh, Maya Latimer, Katharine L. Lewis, Chan Y. Cheah, Pietro Di Ciaccio, Tania Cushion, Eliza A. Hawkes, Sean Harrop, Matthew Ku, Ashlea Campbell, Nada Hamad, Erica M. Wood, Eliza Chung, Pin-Yen Chen & Tara Cochrane. (2023) Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study. Clinical Lymphoma Myeloma and Leukemia 23:5, pages 370-378.
Crossref
Aisling Barrett & Graham P. Collins. (2023) Older patients with Hodgkin Lymphoma: Walking the tightrope of efficacy and toxicity. Frontiers in Oncology 12.
Crossref
Vibor Milunović, Ida Hude, Goran Rinčić, Davor Galušić, Aron Grubešić, Marko Martinović, Nika Popović, Sunčana Divošević, Klara Brčić, Marin Međugorac, Luka Kužat, Dejan Strahija, Stefan Mrđenović, Inga Mandac Smoljanović, Delfa Radić-Krišto, Slavko Gašparov, Igor Aurer & Slobodanka Ostojić Kolonić. (2022) Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review. Biomedicines 10:11, pages 2917.
Crossref
Pallawi Torka, Eugene Przespolewski & Andrew M. Evens. (2022) Treatment Strategies for Advanced Classical Hodgkin Lymphoma in the Times of Dacarbazine Shortage. JCO Oncology Practice 18:7, pages 491-497.
Crossref
George A. Follows, Sally F. Barrington, Kaljit S. Bhuller, Dominic J. Culligan, David J. Cutter, Eve Gallop‐Evans, Shireen Kassam, Wendy Osborne, Shalal Sadullah, William Townsend, Benjamin J. Uttenthal & Graham P. Collins. (2022) Guideline for the first‐line management of Classical Hodgkin Lymphoma — A British Society for Haematology guideline. British Journal of Haematology 197:5, pages 558-572.
Crossref
Waleed Alduaij, Laura K. Hilton, Muntadhar Al Moosawi, Susana Ben-Neriah, Barbara Meissner, Merrill Boyle, Kelly Mekwunye, David W. Scott, Heather A. Leitch & Jeffrey W. Craig. (2022) Concurrent Composite Lymphomas Collectively Bearing Three Diagnostic Entities of Shared Clonal Origin. HemaSphere 6:4, pages e705.
Crossref
Tara Cochrane, Belinda A. Campbell, Shane A. Gangatharan, Maya Latimer, Richard Khor, David R. H. Christie, Michael Gilbertson, Sumita Ratnasingam, Emma Palfreyman, Hui‐Peng Lee, Judith Trotman, Mark Hertzberg & Michael Dickinson. (2021) Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance. Internal Medicine Journal 51:12, pages 2119-2128.
Crossref
Björn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, Evangelos Digkas, Ingrid Glimelius, Ingemar Lagerlöf, Ann‐Sofie Johansson, Marzia Palma, Lotta Hansson, Johan Linderoth, Christina Goldkuhl & Daniel Molin. (2021) Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years. eJHaem 2:3, pages 400-412.
Crossref
Richard T. HoppeRanjana H. AdvaniWeiyun Z. AiRichard F. AmbinderPhilippe ArmandCeleste M. BelloCecil M. BenitezPhilip J. BiermanKirsten M. BoughanBouthaina DabajaLeo I. GordonFrancisco J. Hernandez-IlizaliturriAlex F. HerreraEphraim P. HochbergJiayi HuangPatrick B. JohnstonMark S. KaminskiVaishalee P. KenkreNadia KhanRyan C. LynchKami MaddocksJonathan McConathyMatthew McKinneyMonika MetzgerDavid MorganCarolyn MulroneyRachel RabinovitchKaren C. RosenspireStuart SeropianRanda TaoJane N. WinterJoachim Yahalom, Jennifer L. BurnsNdiya Ogba. (2020) Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 18:6, pages 755-781.
Crossref
Jordan Carter, Kevin A. David, Athena Kritharis & Andrew M. Evens. (2020) Current Treatment Options for Older Patients with Hodgkin Lymphoma. Current Treatment Options in Oncology 21:5.
Crossref
A. Sykorova, H. Mocikova, M. Lukasova, J. Koren, P. Stepankova, V. Prochazka, D. Belada, K. Klaskova, L. Gaherova, K. Chroust, L. Buresova & J. Markova. (2020) Outcome of elderly patients with classical Hodgkin’s lymphoma. Leukemia Research 90, pages 106311.
Crossref
Nancy Bartlett & Grace Triska. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1911 1925.e3 .
Boris Böll & Andrew M. Evens. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma 297 315 .
Andrew M. Evens, Jordan Carter, Kah Poh Loh & Kevin A. David. (2019) Management of older Hodgkin lymphoma patients. Hematology 2019:1, pages 233-242.
Crossref
Pamela B. Allen & Jane N. Winter. (2019) Controversies in the Approach to Initial Therapy of Hodgkin Lymphoma. Current Oncology Reports 21:5.
Crossref
Boris Böll & Helen Görgen. (2019) The treatment of older Hodgkin lymphoma patients. British Journal of Haematology 184:1, pages 82-92.
Crossref
Andrew M. EvensRanjana H. AdvaniIrene B. HelenowskiMichelle FanaleSonali M. SmithBorko D. JovanovicGregory R. BociekAndreas K. KleinJane N. WinterLeo I. GordonPaul A. Hamlin. (2018) Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma. Journal of Clinical Oncology 36:30, pages 3015-3022.
Crossref
Sven Borchmann, Andreas Engert & Boris Böll. (2018) Hodgkin lymphoma in elderly patients. Current Opinion in Oncology 30:5, pages 308-316.
Crossref
Magnus Björkholm, Caroline E. Weibull, Sandra Eloranta, Karin E. Smedby, Ingrid Glimelius & Paul W. Dickman. (2018) Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma-A population-based study from Sweden. European Journal of Haematology 101:1, pages 106-114.
Crossref
Paul J. Bröckelmann & Boris Böll. (2018) Moving things forward in Hodgkin lymphoma. F1000Research 7, pages 1786.
Crossref
Boris Böll. 2018. Geriatrische Onkologie. Geriatrische Onkologie 285 295 .
Heidi Móciková, Alice Sýkorová & Jana Marková. (2017) Hodgkin lymphoma in elderly patients. Onkologie 11:3, pages 121-126.
Crossref
K.D. Kaplanov', T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva & N.B. Lavrishina. (2017) The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity. Clinical oncohematology 10:3, pages 358-365.
Crossref
Boris Böll. 2017. Geriatrische Onkologie. Geriatrische Onkologie 1 11 .
Veronika Bachanova & Joseph M. Connors. (2016) Hodgkin lymphoma in the elderly, pregnant, and HIV-infected. Seminars in Hematology 53:3, pages 203-208.
Crossref
Paul J. Bröckelmann & Andreas Engert. (2015) The GHSG Approach to Treating Hodgkin’s Lymphoma. Current Hematologic Malignancy Reports 10:3, pages 256-265.
Crossref
Aspasia Stamatoullas, Pauline Brice, Reda Bouabdallah, Sylvain Mareschal, Vincent Camus, Ilhem Rahal, Patricia Franchi, Hélène Lanic & Hervé Tilly. (2015) Outcome of patients older than 60 years with classical Hodgkin lymphoma treated with front line ABVD chemotherapy: frequent pulmonary events suggest limiting the use of bleomycin in the elderly. British Journal of Haematology 170:2, pages 179-184.
Crossref
Peter Johnson & Hayley McKenzie. (2015) How I treat advanced classical Hodgkin lymphoma. Blood 125:11, pages 1717-1723.
Crossref
Boris Böll & Andrew M. Evens. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma 271 286 .
Paul Fields. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 169 183 .
Tomasz Wróbel. (2014) Optymalizacja chemio- i radioterapii w leczeniu I linii chłoniaka Hodgkina. Acta Haematologica Polonica 45:2, pages 137-142.
Crossref
Nancy L. Bartlett & Kelley V. Foyil. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2018 2032.e4 .
Deepa Jagadeesh, Catherine Diefenbach & Andrew M. Evens. (2013) XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes. Hematological Oncology 31:S1, pages 69-75.
Crossref
Boris BöllHelen GörgenMichael FuchsAnnette PluetschowHans Theodor EichMario J. BargetziEckhart WeidmannChristian JunghanßRichard GreilAlexander ScherpeOliver SchmalzDennis A. EichenauerBastian von TresckowAchim RotheVolker DiehlAndreas EngertPeter Borchmann. (2013) ABVD in Older Patients With Early-Stage Hodgkin Lymphoma Treated Within the German Hodgkin Study Group HD10 and HD11 Trials. Journal of Clinical Oncology 31:12, pages 1522-1529.
Crossref
Jan Maciej Zaucha, Artur Jurczyszyn, Anna Wojciechowska & Wojciech Rogowski. (2013) Chłoniak Hodgkina u osób w wieku podeszłym. Acta Haematologica Polonica 44:2, pages 156-160.
Crossref
Boris BöllHenning BredenfeldHelen GörgenTeresa HalbsguthHans T. EichMartin SoeklerJana MarkovaUlrich KellerUllrich GraevenStephan KremersMichael Geissler, Guido Trenn, Michael FuchsBastian von TresckowDennis A. EichenauerPeter BorchmannAndreas Engert. (2011) Phase 2 study of PVAG (prednisone, vinblastine, doxorubicin, gemcitabine) in elderly patients with early unfavorable or advanced stage Hodgkin lymphoma. Blood 118:24, pages 6292-6298.
Crossref
Magnus Björkholm, Erik Svedmyr & Jan Sjöberg. (2011) How we treat elderly patients with Hodgkin lymphoma. Current Opinion in Oncology 23:5, pages 421-428.
Crossref
Teresa V. Halbsguth, Boris Böll, Peter Borchmann & Volker Diehl. (2011) The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma. Current Hematologic Malignancy Reports 6:3, pages 164-171.
Crossref
Bo Guo, Hong-Li Zhu, Su-Xia Li, Xue-Chun Lu & Hui Fan. (2011) Individualized Liposomal Doxorubicin-Based Treatment in Elderly Patients with Non-Hodgkin’s Lymphoma. Onkologie 34:4, pages 184-188.
Crossref
Peter Borchmann, Teresa Halbsguth & Stephen J. Proctor. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma 259 272 .
Andrew M. Evens & Sandra J. Horning. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 367 403 .
Teresa V. HalbsguthLucia NogováHorst MuellerMichal Sieniawski, Dennis A. EichenauerThomas SchoberHiltrud Nisters-BackesPeter BorchmannVolker DiehlAndreas EngertAndreas Josting. (2010) Phase 2 study of BACOPP (bleomycin, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone) in older patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 116:12, pages 2026-2032.
Crossref
Jan Walewski, Elżbieta Lampka, Joanna Tajer, Włodzimierz Osiadacz, Ewa Kraszewska, Jolanta B. Krzyżanowska & Janusz Meder. (2009) CHOP-21 for unfavorable Hodgkin’s lymphoma. An exploratory study. Medical Oncology 27:2, pages 262-267.
Crossref
Angela Punnett, Richard W. Tsang & David C. Hodgson. (2010) Hodgkin Lymphoma Across the Age Spectrum: Epidemiology, Therapy, and Late Effects. Seminars in Radiation Oncology 20:1, pages 30-44.
Crossref
T. Halbsguth & P. Borchmann. (2010) Therapiestrategien für die Behandlung des Hodgkin-Lymphoms bei älteren PatientenTherapy strategies for the treatment of Hodgkin’s lymphoma in elderly patients. Der Onkologe 16:1, pages 55-62.
Crossref
S.J. Proctor, J. Wilkinson & M. Sieniawski. (2009) Hodgkin lymphoma in the elderly: A clinical review of treatment and outcome, past, present and future. Critical Reviews in Oncology/Hematology 71:3, pages 222-232.
Crossref
Robert DiazRegina GironésPaula RichartHelena de la CuevaJosé GarcíaMiguel Pastor. (2009) Hodgkin lymphoma in older patients. Aging Health 5:3, pages 395-407.
Crossref
Andrew M Evens, Martin Hutchings & Volker Diehl. (2008) Treatment of Hodgkin lymphoma: the past, present, and future. Nature Clinical Practice Oncology 5:9, pages 543-556.
Crossref
Hermann Brenner, Adam Gondos & Dianne Pulte. (2008) Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood 111:6, pages 2977-2983.
Crossref
Joseph M. Connors. (2008) Challenging Problems: Coincident Pregnancy, HIV Infection, and Older Age. Hematology 2008:1, pages 334-339.
Crossref
Sandra J. Horning. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2353 2369 .
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:4, pages 204-211.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.